Laboratory findings of Libyan patients with COVID-19 in intensive care unit

Abstract :

The 2019 coronavirus disease (COVID-19) was declared by the World Health Organization as a pandemic on 11th March 2020 which spread rapidly all over the world. COVID-19 disease has different clinical presentations, ranging from asymptomatic to severe symptoms. Laboratory findings are important in determining which therapeutic strategies to seek and to identify severe cases initially. In this study, we compared the results of C-reactive protein, D-dimer, blood electrolytes and mean corpuscular hemoglobin concentration between survivors and non-survivors of 22 Libyan patients with COVID-19 present in the intensive care unit at Maitika Isolation Center (Tripoli, Libya) in the period of January to June 2021. We could not detect any significant difference in C-reactive protein between survivors and non-survivors but a significant difference in D-dimer level was observed. Non-survivor COVID-19 patients have a higher level of D-dimer. Moreover, a statistically significant difference in chloride and sodium levels but not in potassium levels were detected. A marked lower mean corpuscular hemoglobin in non-survivor than survivor COVID-19 patients was shown. Thus, these parameters could act as biomarkers for COVID-19 patients.

References

1. Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, kain KC, (2005) Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. The Journal of Infectious Diseases. 191 (2): 193-197. doi: 10.1086/426870
2. Thompson S, Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, Yuen K-Y, Mueller R, Koch D, Sethi S, Rawlinson WD, Clementi M, Erasmus R, Leportier M, Kwon GC, Menezes ME, Patru M-M, Gramegna M, Singh K, Najjar O, Ferrari M, Lippi G, Adeli K, Horvath AR (2020) IFCC interim guidelines on biochemical/ hematological monitoring of COVID-19 patients. Clinical Chemistry and Laboratory Medicine. 58 (12): 2009-2016. doi: 10.1515/cclm-2020-1414
3. Xiang J, Wen J, Yuan X, Xiong S, Zhou XUE, Liu C, Min X (2020) Potential biochemical markers to identify severe cases among COVID-19 patients. medRxiv. 2020.03.19.20034447. doi: 10.1101/2020.03.19.20034447
4. Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G (2020) Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine. 58 (7): 1021-1028. doi: 10.1515/cclm-2020-0369
5. Kumar R, Singh V, Mohanty A, Bahurupi Y, Gupta PK (2021) Corona health- care warriors in India: knowledge, attitude, and practices during COVID-19 outbreak. Journal of Education and Health Promotion. 10 (44): 1-8. doi: 10.4103/jehp.jehp_524_20
6. Pepys MB, Hirschfield GM. C-reactive protein: a critical update (2003) Journal of Clinical Investigations 2003; 111(12): 1805-1812. Epub2003/06/19. doi: 10.1172/JCI18921
7. Wang D, Li R, Wang J, Jiang O, Gao C, Yang J, Ge L, Hu Q (2020) Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infectious Diseases. 20: 519. doi: 10.1186/ s12879-020-05242-w
8. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, Tan J, Xu Y, Song R, Song M, Wang L, Zhang W, Han B, Yang L, Wang X, Zhou G, Zhang T, Li B, Wang Y, Chen Z, Wang X (2020) Neutrophil-to-Lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. Journal of Transitional Medicine. 18 (1): 206. doi: 10.1186/s12967-020-02374-0
9. Sarhan AR, Hussein TA, Flaih MH, Hussein KR (2021) A biochemical analysis of patients with COVID-19 infection. Biochemistry Research International. 2021: 1383830. doi: 10.1155/2021/1383830
10. Riley RS, Gilbert AR, Dalton JB, Pai S, McPherson RA (2016) Widely used types and clinical applications of D-Dimer assay. Laboratory Medicine. 47 (2): 90-102. doi: 10.1093/labmed/lmw001
11. Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH (2016) Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. Wisconsin Medical Journal. 115 (6): 317-321. PMID 29094869.
12. Shu G, Lu H, Du H, Shi J, Wu G (2013) Evaluation of Mindray BC-3600 hematology analyzer in a university hospital. International Journal of Laboratory Hematology. 35 (1): 61-69. doi: 10.1111/j.1751-553X.2012.01464.x
13. Snedecor G, Cochran W (1967) Statistical methods. Oxford & IBH Publishing Co, New Delhi, 1967: 381-418.
14. Mousavi SA, Rad S, Rostami T, Rostami M, Mousavi SA Mirhoseini SA, Kiumarsi A (2020) Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 25(1):383-388. doi: 10.1080/16078454.2020.1833435
15. Arjita IPD, Sabariah S, Anulus A (2020) Complete blood cells findings among covıd-19 in-patients at COVID-19 Reference Hospitals, West Nusa Tenggara. Medical Laboratory Technology Journal. 6 (2): 152-162. doi: 10.31964/ mltj.v6i2.339
16. Pourfridoni M, Abbasnia SM, Shafaei F, Razaviyan J, Heidari-Soureshjani R (2021) Fluid and electrolyte disturbances in COVID-19 and their complications. BioMed Research International. 2021:6667047. doi: 10.1155/ 2021/6667047
17. Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, Aggarwal CS, Vunnam R, Sahu N, Bhatt D, Jones K, Golamari R, Jain R (2020) COVID-19 and older adults: what we know. Journal of the American Geriatrics Society. 68 (5): 926-929. doi: 10.1111/jgs.16472
18. Kang SJ, Jung SI (2020) Age-related morbidity and mortality among patients with COVID- 19. Infection and chemotherapy. 52 (2): 154-164. doi: 10.3947/ic.2020.52.2.154
19. Qin C, Zhou L, Hu Z, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian D-S (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases. 71 (15): 762-768. doi: 10.1093/cid/ciaa248
20. Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab FB, Creel-Bulos CM, Jabaley CS (2020) C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS One. 15 (11): e0242400. doi: 10.1371/ journal.pone.0242400

Citation :

Walli et al. (2022) Laboratory findings of Libyan patients with COVID-19 in intensive care unit. Mediterr J Pharm Pharm Sci. 2 (4): 88-93. [Article number: 94]. https://doi.org/10.5281/zenodo.7479806